Press releaseGothenburg 2016.07.14
Getinge Interim Report January-June 2016
Second quarter of 2016 in brief
- Order intake: -0.7% to SEK 7,460 M (7,516). The order intake grew organically by 3.0%.
- Net sales: -3.5% to SEK 6,927 M (7,181). Net sales fell organically by 0.3%.
- Gross margin: 45.7% (46.4). Affected negatively by currencies.
- EBITA*: +10.2% to SEK 788 M (715).
- Restructuring and integration costs: SEK 133 M (86).
- Profit before tax: +28.0% to SEK 311 M (243).
- Earnings per share: SEK 0.93 (0.71).
- Good cost control: Administrative and selling expenses declined by 8.4%.
- New President of Acute Care Therapies: Jens Viebke
- FDA update: Getinge is still awaiting a decision by the FDA regarding the remediation plan in Hechingen.
- Strengthened customer offering: Launches include a new mobile operating table.
January-June 2016 in brief
- Order intake: -2.2% to SEK 14,384 M (14,708). The order intake grew organically by 0.5%.
- Net sales: -4.2% to SEK 13,304 M (13,893). Net sales fell organically by 1.7%.
- Gross margin: 46.4% (46.6).
- EBITA*: -1.7% to SEK 1,408 M (1,432).
- Restructuring and integration costs: SEK 260 M (270).
- Profit before tax: +20.6% to SEK 468 M (388).
- Earnings per share: SEK 1.39 (1.09).
- The transformation and efficiency-enhancement program was initiated and a Group-wide sales organization was established.
Financial summary
| MSEK | Q2 2016 | Q2 2015 | Change % | Jan-Jun 2016 | Jan-Jun 2015 | Change % | Rolling 12M | FY 2015 |
| Order intake | 7 460 | 7 516 | -0.7% | 14 384 | 14 708 | -2.2% | 30 107 | 30 431 |
| Net sales | 6 927 | 7 181 | -3.5% | 13 304 | 13 893 | -4.2% | 29 646 | 30 235 |
| Gross Profit | 3 167 | 3 331 | -4.9% | 6 178 | 6 473 | -4.6% | 13 868 | 14 163 |
| Gross margin | 45.7% | 46.4% | -0.7% | 46.4% | 46.6% | -0.2% | 46.8% | 46.8% |
| EBITA* | 788 | 715 | 10.2% | 1 408 | 1 432 | -1.7% | 4 155 | 4 179 |
| EBITA margin* | 11.4% | 10.0% | 1.4% | 10.6% | 10.3% | 0.3% | 14.0% | 13.8% |
| Operating profit | 473 | 428 | 10.5% | 789 | 762 | 3.5% | 2 756 | 2 729 |
| Profit before tax | 311 | 243 | 28.0% | 468 | 388 | 20.6% | 2 077 | 1 997 |
| Net profit | 227 | 177 | 28.2% | 342 | 283 | 20.8% | 1 516 | 1 457 |
| Earnings per share | 0.93 | 0.71 | 31.0% | 1.39 | 1.09 | 27.5% | 6.13 | 5.83 |
| Cash flow from operations | 463 | 598 | -22.6% | 1 163 | 1 252 | -7.1% | 3 369 | 3 458 |
* before restructuring, acquisition and integration cost